Floatz logo

2-(1-HEXYLOXYETHYL)-2-DEVINYLPYROPHEOPHORBIDE-A

Advanced Pancreatic Carcinoma

Mayo ClinicSmall moleculePhase 2Dormant
CCC
55/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
40/ 100
Competitive Position
95/ 100

Competitive context

33 Active assets in the Advanced Pancreatic Carcinoma cohort.

Asset / SponsorPhaseRating
Vinorelbine
OHSU Knight Cancer Institute
Phase 2BB
Capecitabine
OHSU Knight Cancer Institute
Phase 2BB
Carboplatin
OHSU Knight Cancer Institute
Phase 2BB
Irinotecan
OHSU Knight Cancer Institute
Phase 2/3BB
Olaparib
National Cancer Institute (NCI)
Phase 2BB

View all 35 →

Same molecule, other indications

2-(1-HEXYLOXYETHYL)-2-DEVINYLPYROPHEOPHORBIDE-A is also rated in:

Liver NeoplasmsDormant
B
Indicative ·
62 / 100
View asset →
Stage II Pancreatic Cancer AJCC v8Dormant
B
Indicative ·
59 / 100
View asset →
Liver MetastasisDormant
B
Indicative ·
57 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →